
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 1000413-72-8 |
| Catalog No. | 2A-1170179 |
| Chinese Name | TAK875-消旋体 |
| Synonyms | Fasiglifam; TAK 875; TAK-875; Fasiglifam (INN); tak875 |
| Molecular Formula | C29H32O7S |
| Molecular Weight | 524.625 |
| Density | 1.3±0.1 g/cm3 |
| Boiling Point | 739.1±60.0 °C at 760 mmHg |
| Storage Condition | 2-8℃ |
| Application | Fasiglifam (TAK-875) is a potent, orally available, selective GPR40 agonist with an EC50 of 72 nM. |
| PubChem ID | 50088191 |
| SMILES | Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2ccc3c(c2)OCC3CC(=O)O)c1 |
| InChI | InChI=1S/C29H32O7S/c1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21(14-22)17-35-24-8-9-26-23(15-28(30)31)18-36-27(26)16-24/h4,6-9,12-14,16,23H,5,10-11,15,17-18H2,1-3H3,(H,30,31)/t23-/m1/s1 |
| InChI Key | BZCALJIHZVNMGJ-HSZRJFAPSA-N |
| Transport Info | Product name: (3S)-6-[[2',6'-dimethyl-4'-[3-(methanesulfonyl)propoxy][1,1'-biphenyl]-3-yl]methoxy]-2,3-dihydro-3-benzofuranacetic acid |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| VU 0357121 | 433967-28-3 | 2A-1170174 |
| Pilaralisib | 934526-89-3 | 2A-1170175 |
| PD 173074 | 219580-11-7 | 2A-1170176 |
| Vicriviroc Malate | 541503-81-5 | 2A-1170177 |
| GSK2838232 | 1443461-21-9 | 2A-1170178 |
| Tarafenacin | 385367-47-5 | 2A-1170180 |
| sp-420 | 1221411-72-8 | 2A-1170181 |
| 2-(4-broMo-2-chlorophenoxy)-N-(4-(N-(4,6-diMethylpyriMidin-2-yl)sulfaMoyl)phenylcarbaMothioyl)acetaMide | 587841-73-4 | 2A-1170182 |
| PD 169316 | 152121-53-4 | 2A-1170185 |
| BIX 02188 | 1094614-84-2 | 2A-1170186 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA